Obesity drugmaker Novo Nordisk's CFO said on Wednesday he was sceptical that U.S. President Donald Trump's executive order to ...

The Trump administration last week canceled the first bargaining session scheduled with the U.S. Food and Drug Administration ...

The U.S. Food and Drug Administration has named Vinay Prasad, an oncologist who has previously criticized FDA leadership and ...

Mexican cartel capo Ovidio Guzman is set to reach a plea deal over drug trafficking charges he faced in the Northern District ...

The U.S. Food and Drug Administration is asking some of its recently fired staff responsible for critically important funding ...

Vertex Pharmaceuticals missed Wall Street estimates for quarterly results on Monday due to lower-than-expected sales of its ...

The U.S. Food and Drug Administration has delayed its decision on marketing approval for Stealth BioTherapeutics' treatment ...

The U.S. Food and Drug Administration will meet its targets for completing reviews of new drugs despite mass firings at the agency under the Trump administration, its chief said.

The White House wants to reduce U.S. health spending by more than a quarter next year, with the National Institutes of Health ...

U.S. health secretary Robert F. Kennedy Jr. reprised various misleading claims about vaccines this week, including that the ...

U.S. President Donald Trump signed an executive order on Monday that aims to reduce the time it takes to approve ...

Obesity drugmaker Novo Nordisk downgraded its 2025 sales forecast on Wednesday, ending a four-year stretch of steady guidance ...